Robin Patel, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    There are no financial relationships to disclose.
    Ineligible company:
    ContraFect, TenNor Therapeutics Limited, Hylomorph and Shionogi
    Topic:
    Research
    Date added:
    Date updated:
    07/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    There are no financial relationships to disclose.
    Ineligible company:
    Curetis, Specific Technologies, Next Gen Diagnostics, PathoQuest, Selux Diagnostics, 1928 Diagnostics, PhAST, and Qvella
    Topic:
    Consultant - Monies go to my employer
    Date added:
    Date updated:
    07/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    There are no financial relationships to disclose.
    Ineligible company:
    Netflix
    Date added:
    Date updated:
    07/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    There are no financial relationships to disclose.
    Ineligible company:
    Dr. Patel has a patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued
    Date added:
    Date updated:
    07/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    There are no financial relationships to disclose.
    Ineligible company:
    Dr. Patel receives an editor’s stipend from IDSA, and honoraria from the NBME, Up-to-Date and the Infectious Diseases Board Review Course
    Date added:
    Date updated:
    07/29/2024
Return to 2022 Infectious Disease Board Review Course